English: I'd like to thank David for bringing forward this extremely important debate. As a cancer survivor, I can attest to the fact that early diagnosis saves lives, because, without an amazing consultant, backed up by a team of nurses and diagnostic staff at Neath Port Talbot Hospital, I would not be here today. Because having had a mammogram, after which I was dancing out the door because they said there was nothing that had shown up on it, an eagle-eyed consultant called me back and said, 'Can you come back, because something just doesn't seem right, even though it is clear?' And this was because the tumour I had in the breast was a translucent tumour and couldn't be shown up then at that time. So, I'd like to thank that eagle-eyed consultant for saving my life, as well as all the friends, family and my fiancé then, who has now become my husband - we had a wonderful wedding to celebrate that, and Suzy Davies can vouch for what a happy, wonderful occasion that was, and a celebration for surviving cancer, Suzy, as you can say. So, I thank everyone that was involved in helping me to recover, and it's been 13 years since, so I think this should give an awful lot of people confidence to go forward in the early stages. Unfortunately, not everyone is as lucky as me, and I don't take any day for granted. In Wales we see just under 20,000 people diagnosed with cancer each year, and, sadly, only 50 per cent of those diagnosed with cancer survive more than 10 years. We perform poorly for cancer survival rates compared with other nations, which is why it is vital that we have a comprehensive and ambitious cancer strategy that addresses our shortfalls in the route to early diagnosis. Early diagnosis is essential for long-term survival and detecting cancer early enough means that survival rates are around 90 per cent. Late diagnosis results in those rates dropping to under 10 per cent. We have an amazing opportunity to do something about that, but changes won't happen overnight. The current cancer delivery plan comes to an end this year, and we can therefore ensure that its replacement is more ambitious, meets the needs of more patients and improves survival rates. There have been amazing developments in cancer diagnostics, such as multiparametric MRI for prostate cancer and the faecal immuno-chemical test, or FIT, for bowel cancer. Both of these improve detection rates and therefore aid early diagnosis, but, due to staffing shortages and regional variation, they're not as effective as they could be. In the case of MPMRI, not every health board provide an MPMRI with dynamic contrast enhancement. My husband went through two invasive and painful biopsies, twice contracted sepsis and twice went through weeks of painful recovery to try and stave off the increase in sepsis diagnosis, if you like. My husband was told that he had prostate cancer. The words used were, 'It is definitely malignant', after the MPMRI scan, 'and it is located in the right-hand side of the prostate'. Now, nearly two years later, we are still unsure whether he has cancer because, after yet another biopsy, we were told good news - it's not cancer after all. So, he is still going through the diagnostic stage, which - . This is almost - I think it's 18 months to two years now. Sadly, his case is far from unique. So, we have some slow progress, but efforts are hampered due to a lack of trained radiologists. The Welsh Government have put more money into improving MRI provision, and have created a Welsh imaging academy that will lead to improvements, but does little to improve survival rates in the short to medium term. The lack of strategic workforce planning has also impacted bowel cancer survival rates. The new FIT test has the potential to revolutionise bowel cancer care, but, due to workforce shortages, we have set the testing threshold much lower than other parts of the developed world. It is therefore little wonder that, for bowel cancer, we are 25 out of 29 in Europe, behind many poorer former Soviet bloc countries. We have to ensure that our new cancer strategy has more ambitious targets, better workforce planning, and strategies to improve screening, uptake and end the postcode lottery. After all, the statistics I have quoted are not entries on a spreadsheet - they are real people: our husbands, our wives, sons, daughters, mothers and fathers, friends and colleagues. So, we owe it to them, to every person with cancer, to do better, and I urge Members to support this motion. Thank you.
Welsh: Hoffwn ddiolch i David am gyflwyno'r ddadl hynod bwysig hon. Fel rhywun sydd wedi goroesi canser, gallaf dystio i'r ffaith bod diagnosis cynnar yn achub bywydau, oherwydd heb feddyg ymgynghorol anhygoel, gyda chefnogaeth tîm o nyrsys a staff diagnostig yn Ysbyty Castell-nedd Port Talbot, ni fuaswn yma heddiw. Oherwydd ar ôl cael mamogram, pan oeddwn yn dawnsio allan drwy'r drws am eu bod wedi dweud nad oedd unrhyw beth i'w weld arno, cefais fy ngalw yn ôl gan feddyg ymgynghorol craff, a ddywedodd, 'A allwch ddod yn ôl, oherwydd ymddengys bod rhywbeth o'i le, er ei fod yn glir?' Ac roedd hyn oherwydd bod y tiwmor a oedd gennyf yn y fron yn diwmor tryleu ac nid oedd modd ei weld ar yr adeg honno. Felly, hoffwn ddiolch i'r meddyg ymgynghorol hwnnw am achub fy mywyd, yn ogystal â fy holl ffrindiau, fy nheulu a fy nyweddi ar y pryd, sydd bellach yn ŵr i mi - cawsom briodas hyfryd i ddathlu hynny, a gall Suzy Davies gadarnhau pa mor hapus a rhyfeddol oedd yr achlysur hwnnw, ac roedd yn ddathliad o oroesi canser, Suzy, fel y gallwch chi ddweud. Felly, diolch i bawb a'm helpodd i wella, ac mae 13 mlynedd wedi bod ers hynny, felly credaf y dylai hyn roi hyder i lawer iawn o bobl symud ymlaen yn y camau cynnar. Yn anffodus, nid yw pawb mor lwcus â mi, ac nid wyf yn cymryd unrhyw ddiwrnod yn ganiataol. Yng Nghymru, rydym yn gweld bron i 20,000 o bobl yn cael diagnosis o ganser bob blwyddyn, ac yn anffodus, dim ond 50 y cant o'r rheini sy'n cael diagnosis o ganser sy'n goroesi am fwy na 10 mlynedd. Rydym yn perfformio'n wael o ran cyfraddau goroesi canser o gymharu â gwledydd eraill, a dyna pam ei bod yn hanfodol fod gennym strategaeth ganser gynhwysfawr ac uchelgeisiol sy'n mynd i'r afael â'n diffygion yn y llwybr at ddiagnosis cynnar. Mae diagnosis cynnar yn hanfodol ar gyfer goroesi yn y tymor hir, ac mae canfod canser yn ddigon cynnar yn golygu bod cyfraddau goroesi oddeutu 90 y cant. Mae diagnosis hwyr yn arwain at ostyngiad yn y cyfraddau hynny i lai na 10 y cant. Mae gennym gyfle anhygoel i wneud rhywbeth am hynny, ond ni fydd newidiadau'n digwydd dros nos. Daw'r cynllun cyflawni cyfredol ar gyfer canser i ben eleni, ac felly gallwn sicrhau bod yr un a ddaw yn ei le yn fwy uchelgeisiol, yn diwallu anghenion mwy o gleifion ac yn gwella cyfraddau goroesi. Cafwyd datblygiadau anhygoel yn niagnosteg canser, fel MRI amlbaramedr ar gyfer canser y prostad a'r prawf imiwnogemegol ysgarthion ar gyfer canser y coluddyn. Mae'r ddau beth yn gwella cyfraddau canfod, ac felly'n cynorthwyo i wneud diagnosis cynnar, ond oherwydd prinder staff ac amrywio rhanbarthol, nid ydynt mor effeithiol ag y gallent fod. Yn achos MRI amlbaramedr, nid yw pob bwrdd iechyd yn ei ddarparu gyda chyferbyneddau deinamig estynedig. Aeth fy ngŵr drwy ddau biopsi ymyrrol a phoenus, cafodd sepsis ddwywaith, a ddwywaith aeth drwy wythnosau o adferiad poenus i geisio cyfyngu ar y diagnosis o gynnydd yn y sepsis, os mynnwch. Dywedwyd wrth fy ngŵr fod ganddo ganser y prostad. Y geiriau a ddefnyddiwyd oedd, 'Mae'n bendant yn falaen', ar ôl y sgan MRI amlbaramedr, 'ac mae wedi'i leoli yn ochr dde'r prostad'. Nawr, bron i ddwy flynedd yn ddiweddarach, rydym yn dal yn ansicr a oes canser arno oherwydd, ar ôl biopsi arall, cawsom newyddion da - nid canser mohono wedi'r cyfan. Felly, mae'n dal i fynd drwy'r cam diagnostig, sydd - . Mae hyn bron - credaf fod 18 mis i ddwy flynedd wedi bod bellach. Yn anffodus, mae ei achos ymhell o fod yn unigryw. Felly, rydym wedi cael ychydig o gynnydd araf, ond mae ymdrechion yn cael eu rhwystro oherwydd diffyg radiolegwyr hyfforddedig. Mae Llywodraeth Cymru wedi rhoi mwy o arian tuag at wella darpariaeth MRI, ac wedi creu academi ddelweddu ar gyfer Cymru a fydd yn arwain at welliannau, ond nid yw hynny'n gwneud llawer i wella cyfraddau goroesi yn y tymor byr i'r tymor canolig. Mae diffyg cynlluniau strategol ar gyfer y gweithlu hefyd wedi effeithio ar gyfraddau goroesi canser y coluddyn. Mae gan y prawf imiwnogemegol ysgarthion newydd botensial i chwyldroi gofal canser y coluddyn, ond oherwydd prinder staff yn y gweithlu, rydym wedi gosod y trothwy profi yn llawer is na rhannau eraill o'r byd datblygedig. Nid yw'n syndod felly ein bod, ar gyfer canser y coluddyn, yn safle rhif 25 allan o 29 yn Ewrop, y tu ôl i lawer o wledydd tlotach yr hen floc Sofietaidd. Mae'n rhaid inni sicrhau bod gan ein strategaeth ganser newydd dargedau mwy uchelgeisiol, gwell cynlluniau ar gyfer y gweithlu, a bod ganddi strategaethau i wella sgrinio, cyfraddau sgrinio a'i bod yn dod â'r loteri cod post hwn i ben. Wedi'r cyfan, nid cofnodion ar daenlen yw'r ystadegau a ddyfynnais - maent yn bobl go iawn: ein gwŷr, ein gwragedd, meibion, merched, mamau a thadau, ffrindiau a chydweithwyr. Felly, ein dyletswydd iddynt, i bob unigolyn â chanser, yw gwneud yn well, ac rwy'n annog yr Aelodau i gefnogi'r cynnig hwn. Diolch.